<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37106121</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1434-9949</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Clinical rheumatology</Title><ISOAbbreviation>Clin Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Folic acid in systemic lupus erythematosus - a new aspect.</ArticleTitle><Pagination><StartPage>1729</StartPage><EndPage>1730</EndPage><MedlinePgn>1729-1730</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10067-023-06604-w</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nikolova-Ganeva</LastName><ForeName>Kalina</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-4901-5265</Identifier><AffiliationInfo><Affiliation>Laboratory of Experimental Immunology, Department of Immunology, The "Stephan Angeloff" Institute of Microbiology, Bulgarian Academy of Sciences, 26 "Acad. Georgy Bonchev" Str, 1113, Sofia, Bulgaria. nikolova_k@microbio.bas.bg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tchorbanov</LastName><ForeName>Andrey</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9161-3325</Identifier><AffiliationInfo><Affiliation>Laboratory of Experimental Immunology, Department of Immunology, The "Stephan Angeloff" Institute of Microbiology, Bulgarian Academy of Sciences, 26 "Acad. Georgy Bonchev" Str, 1113, Sofia, Bulgaria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Immunology, 1517, Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DN 11/3</GrantID><Agency>Bulgarian National Science Fund</Agency><Country/></Grant><Grant><GrantID>2017</GrantID><Agency>Bulgarian National Science Fund</Agency><Country/></Grant><Grant><GrantID>International Partnership "For Women in Science" 2015/16.</GrantID><Agency>Fondation L'Or&#xe9;al</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Rheumatol</MedlineTA><NlmUniqueID>8211469</NlmUniqueID><ISSNLinking>0770-3198</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>935E97BOY8</RegistryNumber><NameOfSubstance UI="D005492">Folic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005492" MajorTopicYN="Y">Folic Acid</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>27</Day><Hour>23</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37106121</ArticleId><ArticleId IdType="doi">10.1007/s10067-023-06604-w</ArticleId><ArticleId IdType="pii">10.1007/s10067-023-06604-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lucock M (2000) Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 71:121&#x2013;138. https://doi.org/10.1006/mgme.2000.3027</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/mgme.2000.3027</ArticleId><ArticleId IdType="pubmed">11001804</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikkelsen K, Apostolopoulos V (2019) Vitamin B12, Folic Acid, and the Immune System, In: Nutrition and Immunity 103&#x2013;114. Mahmoudi, M., Rezaei, N. (eds) Springer, Cham</Citation></Reference><Reference><Citation>Nikolova-Ganeva K, Bradyanova S, Manoylov I, Boneva G, Tchorbanov A (2022) Methyl- rich diet ameliorates lupus-like disease in MRL/lpr mice. Immunobiology 227:152282. https://doi.org/10.1016/j.imbio.2022.152282</Citation></Reference><Reference><Citation>Nikolova-Ganeva K, Vasilev V, Kerezieva S, Tchorbanov A (2023) Impact of folic acid on regulatory B lymphocytes from patients with systemic lupus erythematosus in vitro. Int J Rheum Dis 26:298&#x2013;304. https://doi.org/10.1111/1756-185X.14496</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.14496</ArticleId><ArticleId IdType="pubmed">36385742</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauri C, Menon M (2017) Human regulatory B cells in health and disease: therapeutic potential. J Clin Invest 127:772&#x2013;779. https://doi.org/10.1172/JCI85113</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI85113</ArticleId><ArticleId IdType="pubmed">28248202</ArticleId><ArticleId IdType="pmc">5330739</ArticleId></ArticleIdList></Reference><Reference><Citation>Cham CM, Ko K, Niewold TB (2012) Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus. Clin Dev Immunol 2012:780436. https://doi.org/10.1155/2012/780436</Citation></Reference><Reference><Citation>Guiteras J, Ripoll &#xc9;, Bola&#xf1;os N, De Ramon L, Fontova P, Lloberas N et al (2021) The gene silencing of IRF5 and BLYSS effectively modulates the outcome of experimental lupus nephritis. Mol Ther Nucleic Acids 24:807&#x2013;821. https://doi.org/10.1016/j.omtn.2021.03.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2021.03.019</ArticleId><ArticleId IdType="pubmed">33996261</ArticleId><ArticleId IdType="pmc">8105598</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Wu J, Zhu S, Liu YJ, Chen J (2017) Disease-associated plasmacytoid dendritic cells. Front Immunol 8:1268. https://doi.org/10.3389/fimmu.2017.01268</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01268</ArticleId><ArticleId IdType="pubmed">29085361</ArticleId><ArticleId IdType="pmc">5649186</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;nnblom L, Leonard D (2019) Interferon pathway in SLE: one key to unlocking the mystery of the disease. Lupus Sci Med 6:e000270. https://doi.org/10.1136/lupus-2018-000270</Citation></Reference><Reference><Citation>Chow KT, Wilkins C, Narita M, Green R, Knoll M, Loo YM, Gale M Jr (2018) Differential and Overlapping Immune Programs Regulated by IRF3 and IRF5 in Plasmacytoid Dendritic Cells. J Immunol 201:3036&#x2013;3050. https://doi.org/10.4049/jimmunol.1800221</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1800221</ArticleId><ArticleId IdType="pubmed">30297339</ArticleId></ArticleIdList></Reference><Reference><Citation>Uyeda MJ, Freeborn RA, Cieniewicz B, Romano R, Chen PP, Liu JM et al (2021) BHLHE40 regulates IL-10 and IFN-&#x3b3; production in T cells but does not interfere with human type 1 regulatory T cell differentiation. Front Immunol 12:683680. https://doi.org/10.3389/fimmu.2021.683680</Citation></Reference><Reference><Citation>Rauschmeier R, Reinhardt A, Gustafsson C, Glaros V, Artemov AV, Dunst J et al (2022) Bhlhe40 function in activated B and TFH cells restrains the GC reaction and prevents lymphomagenesis. J Exp Med 219:e20211406. https://doi.org/10.1084/jem.20211406</Citation></Reference><Reference><Citation>Hagberg N, R&#xf6;nnblom L (2015) Systemic lupus erythematosus&#x2013;A Disease with A dysregulated type I interferon system. Scand J Immunol 82:199&#x2013;207. https://doi.org/10.1111/sji.12330</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sji.12330</ArticleId><ArticleId IdType="pubmed">26099519</ArticleId></ArticleIdList></Reference><Reference><Citation>Chyuan IT, Tzeng HT, Chen JY (2019) Signaling pathways of type I and type III interferons and targeted therapies in systemic lupus erythematosus. Cells 8:963. https://doi.org/10.3390/cells8090963</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8090963</ArticleId><ArticleId IdType="pubmed">31450787</ArticleId><ArticleId IdType="pmc">6769759</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xf6;rner T, Tanaka Y, Petri MA, Smolen JS, Wallace DJ, Dow ER et al (2020) Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Lupus Sci Med 7:e000424. https://doi.org/10.1136/lupus-2020-000424</Citation></Reference><Reference><Citation>M&#xf6;lzer C, Wilson HM, Kuffova L, Forrester JV (2021) A Role for Folate in Microbiome-Linked Control of Autoimmunity. J Immunol Res 9998200. https://doi.org/10.1155/2021/9998200</Citation></Reference><Reference><Citation>Zhang L, Qing P, Yang H, Wu Y, Liu Y, Luo Y (2021) Gut microbiome and metabolites in systemic lupus erythematosus: link, mechanisms and intervention. Front Immunol. 12:686501. https://doi.org/10.3389/fimmu.2021.686501</Citation></Reference><Reference><Citation>La Cava A (2019) The influence of diet and obesity on gene expression in SLE. Genes (Basel) 10:405. https://doi.org/10.3390/genes10050405</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes10050405</ArticleId><ArticleId IdType="pubmed">31137916</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi M, Amaretti A, Raimondi S (2011) Folate production by probiotic bacteria. Nutrients 3:118&#x2013;134. https://doi.org/10.3390/nu3010118</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu3010118</ArticleId><ArticleId IdType="pubmed">22254078</ArticleId><ArticleId IdType="pmc">3257725</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon HK, Lee CG, So JS, Chae CS, Hwang JS, Sahoo A et al (2010) Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci USA 107:2159&#x2013;2164. https://doi.org/10.1073/pnas.0904055107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0904055107</ArticleId><ArticleId IdType="pubmed">20080669</ArticleId><ArticleId IdType="pmc">2836639</ArticleId></ArticleIdList></Reference><Reference><Citation>So JS, Lee CG, Kwon HK, Yi HJ, Chae CS, Park JA et al (2008) Lactobacillus casei potentiates induction of oral tolerance in experimental arthritis. Mol Immunol 46:172&#x2013;180. https://doi.org/10.1016/j.molimm.2008.07.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2008.07.038</ArticleId><ArticleId IdType="pubmed">18804867</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>